Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOS VAKLAVAS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1154649440
CMS profile
1306968
Location
BIRMINGHAM, AL

General Payments · PY2018–2024

$78,039.19

  • Reported across 111 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$28,373.40

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $11,434.07 7
Acerta Pharma LLC $8,558.33 10
Genentech USA, Inc. $6,572.27 5
Daiichi Sankyo Inc. $685.00 1
BeiGene USA, Inc. $466.67 1
Gilead Sciences, Inc. $373.33 4
Lilly USA, LLC $118.77 1
GE HEALTHCARE $95.30 1
NOVARTIS PHARMACEUTICALS CORPORATION $69.66 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $233.66 3
PY2019 $5,924.85 15
PY2021 $9,036.81 9
PY2022 $18,051.96 34
PY2023 $16,418.51 18
PY2024 $28,373.40 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $121.84 02/22/2024 Food and Beverage Undisputed 01/23/2026 1105857340 CMS
AstraZeneca Pharmaceuticals LP $350.00 05/02/2024 Grant Undisputed 01/23/2026 1105849220 CMS
AstraZeneca Pharmaceuticals LP $89.12 05/14/2024 Food and Beverage Undisputed 01/23/2026 1105564138 CMS
AstraZeneca Pharmaceuticals LP $3,082.50 05/26/2024 Consulting Fee Undisputed 01/23/2026 1104197765 CMS
AstraZeneca Pharmaceuticals LP $97.93 06/02/2024 Food and Beverage Undisputed 01/23/2026 1104672999 CMS
AstraZeneca Pharmaceuticals LP $118.45 08/01/2024 Food and Beverage Undisputed 01/23/2026 1104359331 CMS
AstraZeneca Pharmaceuticals LP $2,740.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 1105569043 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 1105606005 CMS
AstraZeneca Pharmaceuticals LP $63.49 12/11/2024 Food and Beverage Undisputed 01/23/2026 1104203921 CMS
AstraZeneca Pharmaceuticals LP $525.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 1105563714 CMS
BeiGene USA, Inc. $466.67 05/23/2024 Consulting Fee Undisputed 01/23/2026 1120862433 CMS
Daiichi Sankyo Inc. $685.00 08/28/2024 Consulting Fee Undisputed 01/23/2026 1089493614 CMS
GE HEALTHCARE $95.30 06/04/2024 Food and Beverage Undisputed 01/23/2026 1144683282 CMS
Genentech USA, Inc. $202.05 02/29/2024 Food and Beverage Undisputed 01/23/2026 1132990540 CMS
Genentech USA, Inc. $368.57 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1132990544 CMS
Genentech USA, Inc. $357.42 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1132990548 CMS
Genentech USA, Inc. $19.23 02/29/2024 Food and Beverage Undisputed 01/23/2026 1132990552 CMS
Genentech USA, Inc. $5,625.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1132990556 CMS
Gilead Sciences, Inc. $125.00 05/07/2024 Food and Beverage Undisputed 01/23/2026 1133803716 CMS
Gilead Sciences, Inc. $130.71 08/23/2024 Food and Beverage Undisputed 01/23/2026 1133803718 CMS
Gilead Sciences, Inc. $4.10 11/15/2024 Food and Beverage Undisputed 01/23/2026 1133803720 CMS
Gilead Sciences, Inc. $113.52 12/12/2024 Food and Beverage Undisputed 01/23/2026 1133803722 CMS
Lilly USA, LLC $118.77 02/21/2024 Food and Beverage Undisputed 01/23/2026 1136098866 CMS
Novartis Pharmaceuticals Corporation $32.40 06/08/2024 Food and Beverage Undisputed 01/23/2026 1087420208 CMS
Novartis Pharmaceuticals Corporation $37.26 12/12/2024 Food and Beverage Undisputed 01/23/2026 1087420232 CMS
PFIZER INC. $1,260.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1132012940 CMS
PFIZER INC. $1,400.00 01/04/2024 Honoraria Undisputed 01/23/2026 1131468492 CMS
PFIZER INC. $6,300.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1132012580 CMS
PFIZER INC. $145.14 05/31/2024 Food and Beverage Undisputed 01/23/2026 1131479419 CMS
PFIZER INC. $1,260.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1132040719 CMS
PFIZER INC. $123.93 08/23/2024 Food and Beverage Undisputed 01/23/2026 1131838284 CMS
PFIZER INC. $945.00 09/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132012942 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.